Codexis Inc (CDXS) USD0.0001

Sell:$4.30Buy:$4.31$0.21 (5.12%)

NASDAQ:0.41%
Market closed | Prices delayed by at least 15 minutes
Sell:$4.30
Buy:$4.31
Change:$0.21 (5.12%)
Market closed | Prices delayed by at least 15 minutes
Sell:$4.30
Buy:$4.31
Change:$0.21 (5.12%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Key people

Stephen G. Dilly
Chairman of the Board, President, Chief Executive Officer
Georgia L. Erbez
Chief Financial Officer
Kevin Norrett
Chief Operating Officer
Britton Jimenez
Senior Vice President - Commercial Operations
John Schiffhauer
Senior Vice President - Intellectual Property
Alison Moore
Chief Technology Officer
Margaret Nell Fitzgerald
Chief Legal and Compliance Officer, General Counsel and Secretary
Raymond De Vre
Independent Director
Byron L. Dorgan
Independent Director
Esther Martinborough
Independent Director
H. Stewart Parker
Independent Director
Christos Richards
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US1920051067
  • Market cap
    $335.28m
  • Employees
    174
  • Shares in issue
    81.38m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.